Company / Net Income
RIGEL PHARMACEUTICALS INC Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
$367.0M
FY2025
5-year range
-$58.6M / $367.0M
FY2021-FY2025
Trend
+1999.1%
vs FY2024
Sector context
#25 of 216
Health Care
What the data says
Net Income changed +1999% YoY in FY2025, a notable deviation from the 9-year average annual change of +233%.
Based on SEC 10-K filings.
$367M in FY2025. Top quartile in the Health Care sector.
Improved from -$25M to $367M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 12% in Health CareTop 12% of 216This company $367.0M Sector average $454.1M
▼
-19.2% below sector average
Key checks
Key Insights
- RIGEL PHARMACEUTICALS INC's net income has grown for 3 consecutive years.
- In FY2025, net income increased 1999.1% year-over-year.
- Ranks #25 out of 216 companies in the Health Care sector.
- Lowest net income in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 1.19 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $367.0M | +1999.1% |
| FY2024 | $17.5M | +169.7% |
| FY2023 | -$25.1M | +57.2% |
| FY2022 | -$58.6M | -227.0% |
| FY2021 | -$17.9M | +39.8% |
| FY2020 | -$29.7M | +55.5% |
| FY2019 | -$66.9M | +3.4% |
| FY2018 | -$69.2M | +11.3% |
| FY2017 | -$78.0M | -12.7% |
| FY2016 | -$69.2M | -34.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026